Zenflow GTM brain

category

market profile

• text: Men with enlarged prostates face a choice between medication side effects and invasive procedures; Spring entered US commercial use in 2026.
• text: FDA labeling limits use to symptomatic men within specified prostate and urethral dimensions, making patient selection central to adoption.

personas

• title: Urologist performing office procedures
  pains:

  • Patients defer treatment because they fear sexual side effects or recovery time
  • Need durable symptom relief and a procedure suitable for the office
• title: Urology practice administrator
  pains:

  • Introducing a new procedure requires training, patient selection and reimbursement planning
  • Need to explain the treatment pathway to patients who are hesitant about surgery
• title: Man experiencing BPH symptoms
  pains:

  • Frequent urination and sleep disruption affect quality of life
  • Wants relief without sacrificing sexual function or extended recovery

icp

• text: US urology practices and centers performing minimally invasive BPH procedures in an office setting.
• text: Practices with a meaningful caseload of symptomatic BPH patients meeting the FDA's anatomical criteria.

message pillars

• text: Offer lasting relief for men seeking an alternative to medication.
• text: Preserve sexual function and retain reversibility, subject to individual clinical evaluation.
• text: Position an office-based approach around comfort and recovery.

objections

• objection: Is a new implant appropriate for every BPH patient?
  response: No. Review FDA indications, contraindications and the patient's anatomy with their clinician.
• objection: How does it compare directly with medication?
  response: The company cites independent studies and explicitly says no head-to-head comparison has been conducted.
• objection: Will our practice be reimbursed?
  response: Confirm current coverage, coding and patient costs before offering treatment; public pricing was not found.

competitors

• name: Teleflex
  why: Its UroLift system is another minimally invasive BPH implant option.
• name: Boston Scientific
  why: Its Rezum water vapor therapy competes for minimally invasive BPH procedures.

influencers

• name: Shreya Mehta
  url: https://www.linkedin.com/in/shreya-mehta-49a0575
  why: Founder and CEO discussing Spring and clinical adoption.

keywords

• BPH office procedure
• enlarged prostate treatment without surgery
• minimally invasive BPH implant
• BPH treatment sexual function
• urology BPH alternatives

voice

• reassuring
• patient-centered
• clinically grounded

signals

• text: A urology practice expands office-based BPH procedures or recruits an endourologist.
• text: Patients ask about alternatives to medication or sexual side effects of BPH treatments.

pricing

motion

channels

• urology centers
• medical distributors
• press
• LinkedIn

confidence

Founders

• name: Shreya Mehta
  title: Founder/CTO
  role: CTO